Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

Journal of Bone and Mineral Research

Volumn 29, Issue 9, 2014, Pages 1929-1937

  Solomon, Daniel H ^a   Johnston, Stephen S ^b   Boytsov, Natalie N ^c   McMorrow, Donna ^b   Lane, Joseph M ^d   Krohn, Kelly D ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b IBM WATSON HEALTH   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

HIP FRACTURE; OSTEOPOROSIS; TREATMENT PATTERNS

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; DENOSUMAB; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; OPIATE; PARATHYROID HORMONE[1-34]; RALOXIFENE; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DRUG USE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HEALTH INSURANCE; HIP FRACTURE; HORMONE SUBSTITUTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICARE; OBSERVATIONAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PAGET BONE DISEASE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEX DIFFERENCE; DEMOGRAPHY; HIP FRACTURES; KAPLAN MEIER METHOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; TIME FACTOR; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DEMOGRAPHY; FEMALE; HIP FRACTURES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OSTEOPOROSIS; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; UNITED STATES;

EID: 84903636683     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2202     Document Type: Article

References (34)

1. Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000; 320 (7231): 341-36.
2. Giversen IM,. Time trends of mortality after first hip fractures. Osteoporos Int. 2007; 18 (6): 721-32.
3. Haleem S, Lutchman L, Mayahi R, Grice JE, Parker MJ,. Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury. 2008; 39 (10): 1157-63.
4. Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M,. Epidemiology of hip fractures. Bone. 1996; 18 (1 Suppl): 57S-63S.
5. Cauley JA,. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013; 68 (10): 1243-51.
6. Majumdar SR, Beaupre LA, Harley CH, et al. Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med. 2007; 167 (19): 2110-5.
7. Lönnroos E, Kautiainen H, Karppi P, Hartikainen S, Kiviranta I, Sulkava R,. Incidence of second hip fractures. A population-based study. Osteoporos Int. 2007; 18 (9): 1279-85.
8. Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med. 2007; 167 (18): 1971-6.
9. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation.
10. Cadarette SM, Katz JN, Brookhart MA, et al. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol. 2008; 35 (2): 319-26.
11. Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ,. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010; 58 (4): 650-7.
12. Wright NC, Saag KG, Curtis JR, et al. Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res. 2012; 27 (11): 2325-32.
13. Adams AL, Shi J, Takayanagi M, Dell RM, Funahashi TT, Jacobsen SJ,. Ten-year hip fracture incidence rate trends in a large California population, 1997-2006. Osteoporos Int. 2013; 24 (1): 373-6.
14. Truven Health Analytics. MarketScan Bibliography. Available from: http://marketscan.truvenhealth.com/marketscanuniversity/publications/ 2012%20Truven%20Health%20MarketScan%20Bibliography.pdf.
15. CPT 2009. Chicago: American Medical Association; 2008.
16. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-81.
17. Cox DR,. Regression models and life tables. J R Stat Soc B. 1972; 34: 187-220.
18. Greene WH,. Econometric analysis. 4th ed. Upper Saddle River, NJ: Prentice-Hall; 2000.
19. Hosmer DW, Lemeshow S, May S,. Applied survival analysis: regression modeling of time to event data. Hoboken, NJ: Wiley; 2008.
20. Kolata G,. Researchers puzzled by role of osteoporosis drug in rare thighbone fractures. New York Times [Internet]. 2010 Mar 25 [cited 2014 Apr 11];Sect. A:20. Available from: http://www.nytimes.com/2010/03/25/health/25bone. html.
21. Kolata G,. Drug for bones is newly linked to jaw disease. New York Times [Internet]. 2006 Jun 2 [cited 2014 Apr 11]. Available from. http://www.nytimes. com/2006/06/02/health/02jaw.html.
22. Suresh E, Pazianas M, Abrahamsen B,. Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford). 2014 Jan; 53 (1): 19-31.
23. Beaton DE, Dyer S, Jiang D, et al. Osteoporosis Fracture Clinic Screening Program Evaluation Team. Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program. Osteoporos Int. 2014 Jan; 25 (1): 289-96.
24. Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B,. Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results. Osteoporos Int. 2011 May; 22 (5): 1493-501.
25. Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH,. Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med. 2008; 23 (11): 1815-21.
26. Greene D, Dell RM,. Outcomes of an osteoporosis disease-management program managed by nurse practitioners. J Am Acad Nurse Pract. 2010; 22 (6): 326-9.
27. Newman ED,. A schema for effective osteoporosis management. Dis Manag Health Outcomes. 2003; 11 (10): 611-6.
28. Hawker G, Ridout R, Ricupero M, Jaglal S, Bogoch E,. The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients. Osteoporos Int. 2003; 14 (2): 171-8.
29. Miki RA, Oetgen ME, Kirk J, Insogna KL, Lindskog DM,. Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial. J Bone Joint Surg Am. 2008; 90 (11): 2346-53.
30. Eisman JA, Bogoch ER, Dell R, et al. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res. 2012; 27 (10): 2039-46.
31. Fraser M, McLellan AR,. A fracture liaison service for patients with osteoporotic fractures. Prof Nurse. 2004; 19 (5): 286-90.
32. Wright SA, McNally C, Beringer T, Marsh D, Finch MB,. Osteoporosis fracture liaison experience: the Belfast experience. Rheumatol Int. 2005; 25 (6): 489-90.
33. Charalambous CP, Mosey C, Johnstone E, et al. Improving osteoporosis assessment in the fracture clinic. Ann R Coll Surg Engl. 2009; 91 (7): 596-8.
34. Mitchell PJ,. Fracture liaison services: a systematic approach to secondary fracture prevention. Osteoporosis Review. 2009; 17 (1): 14-6.